Treatment type

Antiretroviral

Treatments and trials using Antiretroviral, with the same country and access zoom as New Developments.

All New Developments

Antiretroviral breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

New Once-Daily Pill for Adults With HIV on Complex Treatment

Bixlenvo (bictegravir and lenacapavir) — a once-daily two-drug pill for adults with HIV who are already undetectable, including people on complex multi-tablet regimens

FDA approval on 27 August 2026 for Bixlenvo (bictegravir 75 mg / lenacapavir 50 mg) tablets — a once-daily complete regimen — to replace the…

This is for adults living with HIV who are already undetectable on a stable regimen — including people taking…

Health Canada/FDA ApprovedUnited StatesCanada

Once-Daily Switch Pill for Adults with Suppressed HIV

Idvynso (doravirine/islatravir) for HIV-1 — switch-only dual tablet

Health Canada and the FDA labelled a once-daily doravirine/islatravir tablet as a switch option for adults with HIV-1 who are already suppressed — not a…

Health Canada and the FDA labelled a once-daily doravirine/islatravir tablet as a switch option for adults…